Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05364645
Title Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Southwest Oncology Group

lung non-small cell carcinoma


Carboplatin + Pemetrexed Disodium

Carboplatin + Pemetrexed Disodium + Selpercatinib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST